Drawing for CERESNANO

USPTO serial 77513018

CERESNANO

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
CHARLON, BARNEY
Law office
TMEG LAW OFFICE 104 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with CERESNANO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Thomas M. Dunlap

THOMAS M. DUNLAP DUNLAP, GRUBB & WEAVER, PLLC199 LIBERTY ST SWLEESBURG, VA 20175-2715UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for scientific laboratory research in the fields of biotechnology, nanotechnology and proteomics, namely, pharmaceutical preparations for collection of tissue samples and fluid samples, pharmaceutical preparations for use in growth hormone screening, cancer screening, anti-doping screening, biomedical screening, pharmaceutical preparations for use in protein analysis, and biomedical analysis, pharmaceutical preparations for diagnosis and treatment of cancer, infectious diseases, genetic inherited disease, and blood disorders, in persons and animals, pharmaceutical preparations in the nature of nucleic acids, genes, enzymes, and proteins for industrial, agricultural, medical and research use in the field of biotechnology, nanotechnology and proteomicsACTIVEMay 1, 2008
009Measuring apparatus for measuring proteins, DNA, RNA, and isoforms of the same, namely, nano-particles for use as measuring apparatus for research in laboratories and medical analysis services using nano-particles and biomarker analysis for collection of tissue samples and fluid sample, growth hormone screening, cancer screening, anti-doping screening, biomedical screening, protein analysis, and biomedical analysis, and diagnosis and treatment of cancer, infectious diseases, genetic inherited disease, and blood disorders, in persons, animals and materialsACTIVEMay 1, 2008
042Scientific and technological research services in the field of biotechnology, nanotechnology and proteomics, namely, collection of tissue samples and fluid samples, growth hormone screening, cancer screening, anti-doping screening, biomedical screening, protein analysis, and biomedical analysis, and diagnosis and treatment of cancer, infectious diseases, genetic inherited disease, and blood disorders, in persons, animals, and materials; scientific and technological research services in the field of biotechnology, nanotechnology and proteomics using fluids, earths, and other materials or substances, namely, nucleic acids, genes, enzymes, and proteins, for scientific, pharmaceutical, industrial, agricultural, medical and research useACTIVEMay 1, 2008
044Medical diagnostic testing in the field of nanotechnology, biotechnology and proteomics namely, using biomarker analysis for collection of tissue samples and fluid samples, growth hormone screening, cancer screening, anti-doping screening, biomedical screening, protein analysis, and biomedical analysis, and diagnosis and treatment of cancer, infectious diseases, genetic inherited disease, and blood disorders, in persons, animals, and materialsACTIVEMay 1, 2008

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Nov 23, 2009MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Nov 21, 2009ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
May 15, 2009DOCKASSIGNED TO EXAMINER—
Apr 23, 2009GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 23, 2009GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 23, 2009CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 7, 2009TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 6, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 6, 2009TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 9, 2008GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 9, 2008GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 9, 2008CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 6, 2008DOCKASSIGNED TO EXAMINER—
Jul 8, 2008MPMKNOTICE OF PSEUDO MARK MAILED—
Jul 7, 2008NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance